FRCTX
Price
$6.55
Change
+$0.03 (+0.46%)
Updated
Apr 24 closing price
Net Assets
12.37B
TECFX
Price
$16.20
Change
+$0.07 (+0.43%)
Updated
Apr 24 closing price
Net Assets
3.18B
Ad is loading...

FRCTX vs TECFX

Header iconFRCTX vs TECFX Comparison
Open Charts FRCTX vs TECFXBanner chart's image
Franklin CA Tax Free Income C
Price$6.55
Change+$0.03 (+0.46%)
VolumeN/A
Net Assets12.37B
American Funds Tax-Exempt Fund of CA F1
Price$16.20
Change+$0.07 (+0.43%)
VolumeN/A
Net Assets3.18B
FRCTX vs TECFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRCTX vs. TECFX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRCTX is a Hold and TECFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FRCTX has more cash in the bank: 12.4B vs. TECFX (3.18B). FRCTX pays higher dividends than TECFX: FRCTX (3.11) vs TECFX (2.81). FRCTX was incepted earlier than TECFX: FRCTX (30 years) vs TECFX (24 years). FRCTX (1.16) is less costly to investors than TECFX (0.66). TECFX is a more actively managed with annual turnover of: 23.00 vs. FRCTX (14.01). FRCTX (1000) and TECFX (1000) have matching initial minimum investment requirements. FRCTX annual gain was more profitable for investors over the last year : -0.41 vs. TECFX (-1.48). FRCTX return over 5 years is better than : -3.47 vs. TECFX (-6.14).
FRCTXTECFXFRCTX / TECFX
Total Expense Ratio1.160.66176%
Annual Report Gross Expense Ratio1.160.66176%
Fund Existence30 years24 years-
Gain YTD-3.519-2.994118%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets12.4B3.18B390%
Annual Yield % from dividends3.112.81111%
Returns for 1 year-0.41-1.4828%
Returns for 3 years0.93-1.63-57%
Returns for 5 years-3.47-6.1457%
Returns for 10 years-2.64-6.0244%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLGX91.80N/A
N/A
Rydex S&P 500 Pure Growth A
JGISX72.81N/A
N/A
JPMorgan U.S. GARP Equity R6
EQNAX19.97N/A
N/A
MFS Equity Income A
SHSKX65.93N/A
N/A
BlackRock Health Sciences Opps K
FIFQX20.00N/A
N/A
Fidelity Advisor Founders C